325 related articles for article (PubMed ID: 24886089)
1. DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells.
Bachmann SB; Frommel SC; Camicia R; Winkler HC; Santoro R; Hassa PO
Mol Cancer; 2014 May; 13():125. PubMed ID: 24886089
[TBL] [Abstract][Full Text] [Related]
2. DTX3L/ARTD9 contributes to inflammation of fibroblast-like synoviocytes by increasing STAT1 translocation.
Hong R; Wang Y; Dong H; Geng R
Tissue Cell; 2020 Jun; 64():101339. PubMed ID: 32473705
[TBL] [Abstract][Full Text] [Related]
3. BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFNγ-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma.
Camicia R; Bachmann SB; Winkler HC; Beer M; Tinguely M; Haralambieva E; Hassa PO
J Cell Sci; 2013 May; 126(Pt 9):1969-80. PubMed ID: 23487038
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9.
Yang CS; Jividen K; Spencer A; Dworak N; Ni L; Oostdyk LT; Chatterjee M; Kuśmider B; Reon B; Parlak M; Gorbunova V; Abbas T; Jeffery E; Sherman NE; Paschal BM
Mol Cell; 2017 May; 66(4):503-516.e5. PubMed ID: 28525742
[TBL] [Abstract][Full Text] [Related]
5. Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.
Camicia R; Winkler HC; Hassa PO
Mol Cancer; 2015 Dec; 14():207. PubMed ID: 26654227
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of the DTX3L-PARP9 complex reveals determinants for high-affinity heterodimerization and multimeric assembly.
Ashok Y; Vela-Rodríguez C; Yang C; Alanen HI; Liu F; Paschal BM; Lehtiö L
Biochem J; 2022 Feb; 479(3):289-304. PubMed ID: 35037691
[TBL] [Abstract][Full Text] [Related]
7. KH-like Domains in PARP9/DTX3L and PARP14 Coordinate Protein-Protein Interactions to Promote Cancer Cell Survival.
Saleh H; Liloglou T; Rigden DJ; Parsons JL; Grundy GJ
J Mol Biol; 2024 Feb; 436(4):168434. PubMed ID: 38182103
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Intracellular Auto-Modification Levels of ARTD10 Using Mono-ADP-Ribose-Specific Macrodomains 2 and 3 of Murine Artd8.
Bütepage M; Krieg S; Eckei L; Li J; Rossetti G; Verheugd P; Lüscher B
Methods Mol Biol; 2018; 1813():41-63. PubMed ID: 30097860
[TBL] [Abstract][Full Text] [Related]
9. A Study into the ADP-Ribosylome of IFN-γ-Stimulated THP-1 Human Macrophage-like Cells Identifies ARTD8/PARP14 and ARTD9/PARP9 ADP-Ribosylation.
Higashi H; Maejima T; Lee LH; Yamazaki Y; Hottiger MO; Singh SA; Aikawa M
J Proteome Res; 2019 Apr; 18(4):1607-1622. PubMed ID: 30848916
[TBL] [Abstract][Full Text] [Related]
10. The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling.
Russo LC; Tomasin R; Matos IA; Manucci AC; Sowa ST; Dale K; Caldecott KW; Lehtiö L; Schechtman D; Meotti FC; Bruni-Cardoso A; Hoch NC
J Biol Chem; 2021 Sep; 297(3):101041. PubMed ID: 34358560
[TBL] [Abstract][Full Text] [Related]
11. Androgen signaling uses a writer and a reader of ADP-ribosylation to regulate protein complex assembly.
Yang CS; Jividen K; Kamata T; Dworak N; Oostdyk L; Remlein B; Pourfarjam Y; Kim IK; Du KP; Abbas T; Sherman NE; Wotton D; Paschal BM
Nat Commun; 2021 May; 12(1):2705. PubMed ID: 33976187
[TBL] [Abstract][Full Text] [Related]
12. Activities and binding partners of E3 ubiquitin ligase DTX3L and its roles in cancer.
Vela-Rodríguez C; Lehtiö L
Biochem Soc Trans; 2022 Dec; 50(6):1683-1692. PubMed ID: 36421918
[TBL] [Abstract][Full Text] [Related]
13. PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection.
Zhang Y; Mao D; Roswit WT; Jin X; Patel AC; Patel DA; Agapov E; Wang Z; Tidwell RM; Atkinson JJ; Huang G; McCarthy R; Yu J; Yun NE; Paessler S; Lawson TG; Omattage NS; Brett TJ; Holtzman MJ
Nat Immunol; 2015 Dec; 16(12):1215-27. PubMed ID: 26479788
[TBL] [Abstract][Full Text] [Related]
14. Synthetic Dual Cysteine-ADP Ribosylated Peptides from the Androgen Receptor are Recognized by the DTX3L/PARP9 Complex.
Wijngaarden S; Yang C; Vela-Rodríguez C; Lehtiö L; Overkleeft HS; Paschal BM; Filippov DV
ACS Chem Biol; 2023 Nov; 18(11):2377-2384. PubMed ID: 37939374
[TBL] [Abstract][Full Text] [Related]
15. Deltex-3-like (DTX3L) stimulates metastasis of melanoma through FAK/PI3K/AKT but not MEK/ERK pathway.
Thang ND; Yajima I; Kumasaka MY; Iida M; Suzuki T; Kato M
Oncotarget; 2015 Jun; 6(16):14290-9. PubMed ID: 26033450
[TBL] [Abstract][Full Text] [Related]
16. DTX3L Accelerates Pancreatic cancer Progression via FAK/PI3K/AKT Axis.
Chen L; Niu W; Zang H; Qiu Y
Biochem Genet; 2024 Apr; 62(2):814-830. PubMed ID: 37460862
[TBL] [Abstract][Full Text] [Related]
17. The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI).
Sun Y; Jia X; Gao Q; Liu X; Hou L
IUBMB Life; 2017 Jan; 69(1):16-21. PubMed ID: 27862841
[TBL] [Abstract][Full Text] [Related]
18. Oligomerization mediated by the D2 domain of DTX3L is critical for DTX3L-PARP9 reading function of mono-ADP-ribosylated androgen receptor.
Vela-Rodríguez C; Yang C; Alanen HI; Eki R; Abbas TA; Maksimainen MM; Glumoff T; Duman R; Wagner A; Paschal BM; Lehtiö L
Protein Sci; 2024 Apr; 33(4):e4945. PubMed ID: 38511494
[TBL] [Abstract][Full Text] [Related]
19. BAL1 and its partner E3 ligase, BBAP, link Poly(ADP-ribose) activation, ubiquitylation, and double-strand DNA repair independent of ATM, MDC1, and RNF8.
Yan Q; Xu R; Zhu L; Cheng X; Wang Z; Manis J; Shipp MA
Mol Cell Biol; 2013 Feb; 33(4):845-57. PubMed ID: 23230272
[TBL] [Abstract][Full Text] [Related]
20. DTX3L is upregulated in glioma and is associated with glioma progression.
Xu P; Tao X; Zhao C; Huang Q; Chang H; Ban N; Bei Y; Xia X; Shen C; Wang K; Xu L; Wu P; Ren J; Wang D
Int J Mol Med; 2017 Aug; 40(2):491-498. PubMed ID: 28627634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
